NATURE . COM {}

Matching Content Categories {📚}

• Science
• Health & Fitness
• Education

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 21,169,014 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (9)

Reseller Advertisers (40)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

Display Ads ~ $203,300 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $135,514 to $372,663.

Keywords {🔍}

cancer, breast, cells, pubmed, irs, article, prb, cas, fig, google, scholar, cell, receptor, expression, models, phosphopr, mcf, insulin, gene, central, target, resistance, tumoursphere, data, tamr, genes, progesterone, endocrine, signalling, tumours, tamoxifen, formation, expressing, nature, metastatic, treatment, usa, levels, primary, pdx, tumourspheres, igfrβ, growth, supplementary, receptors, lesions, activity, protein, previously, relative,

Topics {✒️}

nature portfolio author information authors goat anti-rabbit igg-hrp breast cancer research goat anti-mouse igg-hrp sumo-deficient/phospho-mimic pr phospho-pr-specific gene signatures dextran-coated charcoal-stripped fbs prognostic index nature 523 nature 540 nature target phospho-pr-specific signalling stress-sensing protein kinases real-time quantitative pcr standard light/dark cycle mitogen-activated protein kinase 10 μm paraffin sections reprints key er/pr-binding partner irs-1/phospho-pr target genes single-cell phospho-pr levels er/pr/c-src complexes anti-rabbit ig mp-7401 metastasis nod/scid/iliirg−/− er-positive breast cancer er+ breast tumors svetlana estrogen receptor-alpha regulates endocrine-resistant breast cancer targeting phospho-pr/irs-1 crosstalk robust phospho-pr staining anti-mouse ig mp-7402 er/ps294-pr/irs-1 complexes phospho-pr gene signature specific pathogen-free housing data linking phospho-pr ultra-low attachment plates ultra-low attachment dishes references siegel igf1rβ/ir hybrid receptors plenti cmv-neo vector er-nfĸb-driven stem cyclin-dependent kinase 4/6 phospho-pr target genes 16-gene phospho-ser294 pr advanced breast cancer 1 ml phosphate-buffered saline phenol red-free imem author correspondence original author

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer
         description:Progesterone receptors (PR) are potent modifiers of endocrine responses. In aberrant signalling cancer contexts, phosphorylation events dramatically alter steroid hormone receptor action. The transcriptomes of primary tumours and metastases in mice harbouring ER+ breast cancer patient-derived xenografts (PDXs) were analysed following single-cell RNAseq. In vitro assays were employed to delineate mechanisms of endocrine resistance and stemness. A 16-gene phospho-Ser294 PR (p-PR) signature predicted poor outcome in ER+ breast cancer. Relative to primary PDX tumours, metastatic lesions expressed abundant p-PR and exhibited an activated PR gene programme with elevated expression of PGR and IRS-1. Breast cancer models of activated PR lost the expression of IGF1R and acquired insulin hypersensitivity with tamoxifen insensitivity. Activated p-PR+ breast cancer cells formed increased tumourspheres with enlarged ALDH+ and CD24−/CD44 populations. E2 induced PR/IRS-1 interaction and exchange of IGF1Rβ for IRS-1 in p-PR-containing transcriptional complexes. Inhibition of IRS-1 or IR and inducible IRS-1 knockdown reduced tumourspheres. Endocrine-resistant models of luminal B breast cancer induced p-PR in 3D cultures and required PR and IRS-1 for tumoursphere formation. Phospho-PR-B cooperates with IRS-1 to promote outgrowth of endocrine-resistant and stem-like breast cancer cells. Targeting phospho-PR/IRS-1 crosstalk may block the emergence of endocrine resistance.
         datePublished:2020-11-04T00:00:00Z
         dateModified:2020-11-04T00:00:00Z
         pageStart:217
         pageEnd:227
         sameAs:https://doi.org/10.1038/s41416-020-01094-y
         keywords:
            Breast cancer
            Cell biology
            Biomedicine
            general
            Cancer Research
            Epidemiology
            Molecular Medicine
            Oncology
            Drug Resistance
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Figa_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig5_HTML.png
         isPartOf:
            name:British Journal of Cancer
            issn:
               1532-1827
               0007-0920
            volumeNumber:124
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Amy R. Dwyer
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thu H. Truong
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carlos Perez Kerkvliet
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kiran V. Paul
               affiliation:
                     name:University of Colorado Anschutz Medical Campus
                     address:
                        name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter Kabos
               affiliation:
                     name:University of Colorado Anschutz Medical Campus
                     address:
                        name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carol A. Sartorius
               affiliation:
                     name:University of Colorado Anschutz Medical Campus
                     address:
                        name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carol A. Lange
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Minnesota
                     address:
                        name:Departments of Medicine (Division of Hematology, Oncology, and Transplantation) and Pharmacology, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer
      description:Progesterone receptors (PR) are potent modifiers of endocrine responses. In aberrant signalling cancer contexts, phosphorylation events dramatically alter steroid hormone receptor action. The transcriptomes of primary tumours and metastases in mice harbouring ER+ breast cancer patient-derived xenografts (PDXs) were analysed following single-cell RNAseq. In vitro assays were employed to delineate mechanisms of endocrine resistance and stemness. A 16-gene phospho-Ser294 PR (p-PR) signature predicted poor outcome in ER+ breast cancer. Relative to primary PDX tumours, metastatic lesions expressed abundant p-PR and exhibited an activated PR gene programme with elevated expression of PGR and IRS-1. Breast cancer models of activated PR lost the expression of IGF1R and acquired insulin hypersensitivity with tamoxifen insensitivity. Activated p-PR+ breast cancer cells formed increased tumourspheres with enlarged ALDH+ and CD24−/CD44 populations. E2 induced PR/IRS-1 interaction and exchange of IGF1Rβ for IRS-1 in p-PR-containing transcriptional complexes. Inhibition of IRS-1 or IR and inducible IRS-1 knockdown reduced tumourspheres. Endocrine-resistant models of luminal B breast cancer induced p-PR in 3D cultures and required PR and IRS-1 for tumoursphere formation. Phospho-PR-B cooperates with IRS-1 to promote outgrowth of endocrine-resistant and stem-like breast cancer cells. Targeting phospho-PR/IRS-1 crosstalk may block the emergence of endocrine resistance.
      datePublished:2020-11-04T00:00:00Z
      dateModified:2020-11-04T00:00:00Z
      pageStart:217
      pageEnd:227
      sameAs:https://doi.org/10.1038/s41416-020-01094-y
      keywords:
         Breast cancer
         Cell biology
         Biomedicine
         general
         Cancer Research
         Epidemiology
         Molecular Medicine
         Oncology
         Drug Resistance
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Figa_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_Fig5_HTML.png
      isPartOf:
         name:British Journal of Cancer
         issn:
            1532-1827
            0007-0920
         volumeNumber:124
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Amy R. Dwyer
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thu H. Truong
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carlos Perez Kerkvliet
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kiran V. Paul
            affiliation:
                  name:University of Colorado Anschutz Medical Campus
                  address:
                     name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter Kabos
            affiliation:
                  name:University of Colorado Anschutz Medical Campus
                  address:
                     name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carol A. Sartorius
            affiliation:
                  name:University of Colorado Anschutz Medical Campus
                  address:
                     name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carol A. Lange
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Minnesota
                  address:
                     name:Departments of Medicine (Division of Hematology, Oncology, and Transplantation) and Pharmacology, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:British Journal of Cancer
      issn:
         1532-1827
         0007-0920
      volumeNumber:124
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Minnesota
      address:
         name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Colorado Anschutz Medical Campus
      address:
         name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
         type:PostalAddress
      name:University of Colorado Anschutz Medical Campus
      address:
         name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
         type:PostalAddress
      name:University of Colorado Anschutz Medical Campus
      address:
         name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Departments of Medicine (Division of Hematology, Oncology, and Transplantation) and Pharmacology, University of Minnesota, Minneapolis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Amy R. Dwyer
      affiliation:
            name:University of Minnesota
            address:
               name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:Thu H. Truong
      affiliation:
            name:University of Minnesota
            address:
               name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:Carlos Perez Kerkvliet
      affiliation:
            name:University of Minnesota
            address:
               name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:Kiran V. Paul
      affiliation:
            name:University of Colorado Anschutz Medical Campus
            address:
               name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
               type:PostalAddress
            type:Organization
      name:Peter Kabos
      affiliation:
            name:University of Colorado Anschutz Medical Campus
            address:
               name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
               type:PostalAddress
            type:Organization
      name:Carol A. Sartorius
      affiliation:
            name:University of Colorado Anschutz Medical Campus
            address:
               name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
               type:PostalAddress
            type:Organization
      name:Carol A. Lange
      affiliation:
            name:University of Minnesota
            address:
               name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
            name:University of Minnesota
            address:
               name:Departments of Medicine (Division of Hematology, Oncology, and Transplantation) and Pharmacology, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
      name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
      name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
      name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
      name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
      name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
      name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
      name:Departments of Medicine (Division of Hematology, Oncology, and Transplantation) and Pharmacology, University of Minnesota, Minneapolis, USA

Social Networks {👍}(1)

• https://twitter.com/BrJCancer

External Links {🔗}(209)

• http://bioinformatica.mty.itesm.mx:8080/Biomatec/SurvivaX.jsp
• http://rsbweb.nih.gov/ij/
• https://doi.org/10.3322%2Fcaac.21332
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26742998
• http://scholar.google.com/scholar_lookup?&title=Cancer%20statistics%2C%202016&journal=CA%20Cancer%20J.%20Clin.&doi=10.3322%2Fcaac.21332&volume=66&pages=7-30&publication_year=2016&author=Siegel%2CRL&author=Miller%2CKD&author=Jemal%2CA
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11171938
• http://scholar.google.com/scholar_lookup?&title=Cellular%20and%20molecular%20pharmacology%20of%20antiestrogen%20action%20and%20resistance&journal=Pharmacol.%20Rev.&volume=53&publication_year=2001&author=Clarke%2CR&author=Leonessa%2CF&author=Welch%2CJN&author=Skaar%2CTC
• https://doi.org/10.1200%2FJCO.2018.78.9909
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29860922
• http://scholar.google.com/scholar_lookup?&title=Phase%20III%20randomized%20study%20of%20ribociclib%20and%20fulvestrant%20in%20hormone%20receptor-positive%2C%20human%20epidermal%20growth%20factor%20receptor%202-negative%20advanced%20breast%20cancer%3A%20MONALEESA-3&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.2018.78.9909&volume=36&pages=2465-2472&publication_year=2018&author=Slamon%2CDJ&author=Neven%2CP&author=Chia%2CS&author=Fasching%2CPA&author=Laurentiis%2CM&author=Im%2CSA
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28856074
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574633
• http://scholar.google.com/scholar_lookup?&title=Utilizing%20tumor%20and%20plasma%20liquid%20biopsy%20in%20treatment%20decision%20making%20for%20an%20estrogen%20receptor-positive%20advanced%20breast%20cancer%20patient&journal=Cureus&volume=9&publication_year=2017&author=Xu%2CB&author=Krie%2CA&author=De%2CP&author=Williams%2CC&author=Elsey%2CR&author=Klein%2CJ
• https://doi.org/10.1093%2Fannonc%2Fmdx784
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29236940
• http://scholar.google.com/scholar_lookup?&title=Polyclonal%20RB1%20mutations%20and%20acquired%20resistance%20to%20CDK%204%2F6%20inhibitors%20in%20patients%20with%20metastatic%20breast%20cancer&journal=Ann.%20Oncol.&doi=10.1093%2Fannonc%2Fmdx784&volume=29&pages=640-645&publication_year=2018&author=Condorelli%2CR&author=Spring%2CL&author=O%E2%80%99Shaughnessy%2CJ&author=Lacroix%2CL&author=Bailleux%2CC&author=Scott%2CV
• https://doi.org/10.1038%2Fnature14583
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26153859
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650274
• http://scholar.google.com/scholar_lookup?&title=Progesterone%20receptor%20modulates%20ERalpha%20action%20in%20breast%20cancer&journal=Nature&doi=10.1038%2Fnature14583&volume=523&pages=313-317&publication_year=2015&author=Mohammed%2CH&author=Russell%2CIA&author=Stark%2CR&author=Rueda%2COM&author=Hickey%2CTE&author=Tarulli%2CGA
• https://doi.org/10.1210%2Fme.2008-0267
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19147702
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725766
• http://scholar.google.com/scholar_lookup?&title=Progesterone%20receptor%20B%20recruits%20a%20repressor%20complex%20to%20a%20half-PRE%20site%20of%20the%20estrogen%20receptor%20alpha%20gene%20promoter&journal=Mol.%20Endocrinol.&doi=10.1210%2Fme.2008-0267&volume=23&pages=454-465&publication_year=2009&author=Amicis%2CF&author=Zupo%2CS&author=Panno%2CML&author=Malivindi%2CR&author=Giordano%2CF&author=Barone%2CI
• https://doi.org/10.1126%2Fsciadv.1501924
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27386569
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928895
• http://scholar.google.com/scholar_lookup?&title=Genomic%20agonism%20and%20phenotypic%20antagonism%20between%20estrogen%20and%20progesterone%20receptors%20in%20breast%20cancer&journal=Sci.%20Adv.&doi=10.1126%2Fsciadv.1501924&volume=2&publication_year=2016&author=Singhal%2CH&author=Greene%2CME&author=Tarulli%2CG&author=Zarnke%2CAL&author=Bourgo%2CRJ&author=Laine%2CM
• https://doi.org/10.1128%2FMCB.24.24.10542-10557.2004
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15572662
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC533997
• http://scholar.google.com/scholar_lookup?&title=Phosphorylation%20of%20progesterone%20receptor%20serine%20400%20mediates%20ligand-independent%20transcriptional%20activity%20in%20response%20to%20activation%20of%20cyclin-dependent%20protein%20kinase%202&journal=Mol.%20Cell.%20Biol.&doi=10.1128%2FMCB.24.24.10542-10557.2004&volume=24&pages=10542-10557&publication_year=2004&author=Pierson-Mullany%2CLK&author=Lange%2CCA
• https://doi.org/10.1210%2Fme.2007-0437
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18202149
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276470
• http://scholar.google.com/scholar_lookup?&title=Progesterone%20receptor%20rapid%20signaling%20mediates%20serine%20345%20phosphorylation%20and%20tethering%20to%20specificity%20protein%201%20transcription%20factors&journal=Mol.%20Endocrinol.&doi=10.1210%2Fme.2007-0437&volume=22&pages=823-837&publication_year=2008&author=Faivre%2CEJ&author=Daniel%2CAR&author=Hillard%2CCJ&author=Lange%2CCA
• https://doi.org/10.1210%2Fme.2013-1196
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24606123
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968407
• http://scholar.google.com/scholar_lookup?&title=Progesterone%20receptor-cyclin%20D1%20complexes%20induce%20cell%20cycle-dependent%20transcriptional%20programs%20in%20breast%20cancer%20cells&journal=Mol.%20Endocrinol.&doi=10.1210%2Fme.2013-1196&volume=28&pages=442-457&publication_year=2014&author=Dressing%2CGE&author=Knutson%2CTP&author=Schiewer%2CMJ&author=Daniel%2CAR&author=Hagan%2CCR&author=Diep%2CCH
• https://doi.org/10.1128%2FMCB.01246-10
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21518957
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133426
• http://scholar.google.com/scholar_lookup?&title=ck2-dependent%20phosphorylation%20of%20progesterone%20receptors%20%28PR%29%20on%20Ser81%20regulates%20PR-B%20isoform-specific%20target%20gene%20expression%20in%20breast%20cancer%20cells&journal=Mol.%20Cell%20Biol.&doi=10.1128%2FMCB.01246-10&volume=31&pages=2439-2452&publication_year=2011&author=Hagan%2CCR&author=Regan%2CTM&author=Dressing%2CGE&author=Lange%2CCA
• https://link.springer.com/doi/10.1186/bcr3211
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22697792
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446358
• http://scholar.google.com/scholar_lookup?&title=Phosphorylated%20and%20sumoylation-deficient%20progesterone%20receptors%20drive%20proliferative%20gene%20signatures%20during%20breast%20cancer%20progression&journal=Breast%20Cancer%20Res.&doi=10.1186%2Fbcr3211&volume=14&publication_year=2012&author=Knutson%2CTP&author=Daniel%2CAR&author=Fan%2CD&author=Silverstein%2CKA&author=Covington%2CKR&author=Fuqua%2CSA
• https://link.springer.com/doi/10.1186/s13045-017-0462-7
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28412963
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392969
• http://scholar.google.com/scholar_lookup?&title=Posttranslationally%20modified%20progesterone%20receptors%20direct%20ligand-specific%20expression%20of%20breast%20cancer%20stem%20cell-associated%20gene%20programs&journal=J.%20Hematol.%20Oncol.&doi=10.1186%2Fs13045-017-0462-7&volume=10&publication_year=2017&author=Knutson%2CTP&author=Truong%2CTH&author=Ma%2CS&author=Brady%2CNJ&author=Sullivan%2CME&author=Raj%2CG
• https://doi.org/10.1210%2Fen.2018-00990
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30597041
• http://scholar.google.com/scholar_lookup?&title=Phosphorylated%20progesterone%20receptor%20isoforms%20mediate%20opposing%20stem%20cell%20and%20proliferative%20breast%20cancer%20cell%20fates&journal=Endocrinology&doi=10.1210%2Fen.2018-00990&volume=160&pages=430-446&publication_year=2019&author=Truong%2CTH&author=Dwyer%2CAR&author=Diep%2CCH&author=Hu%2CH&author=Hagen%2CKM&author=Lange%2CCA
• https://doi.org/10.1038%2Fnature20785
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27974799
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390864
• http://scholar.google.com/scholar_lookup?&title=Early%20dissemination%20seeds%20metastasis%20in%20breast%20cancer&journal=Nature&doi=10.1038%2Fnature20785&volume=540&pages=552-558&publication_year=2016&author=Hosseini%2CH&author=Obradovic%2CMMS&author=Hoffmann%2CM&author=Harper%2CKL&author=Sosa%2CMS&author=Werner-Klein%2CM
• https://doi.org/10.1038%2Fnrc3215
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22337149
• http://scholar.google.com/scholar_lookup?&title=The%20insulin%20and%20insulin-like%20growth%20factor%20receptor%20family%20in%20neoplasia%3A%20an%20update&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2Fnrc3215&volume=12&pages=159-169&publication_year=2012&author=Pollak%2CM
• https://link.springer.com/doi/10.1007/s10911-012-9268-y
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23054135
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534944
• http://scholar.google.com/scholar_lookup?&title=Targeting%20insulin%20and%20insulin-like%20growth%20factor%20signaling%20in%20breast%20cancer&journal=J.%20Mammary%20Gland%20Biol.%20Neoplasia&doi=10.1007%2Fs10911-012-9268-y&volume=17&pages=251-261&publication_year=2012&author=Yang%2CY&author=Yee%2CD
• https://doi.org/10.1038%2Fsj.bjc.6603354
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17043687
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360584
• http://scholar.google.com/scholar_lookup?&title=Insulin%20receptor%20substrates%20mediate%20distinct%20biological%20responses%20to%20insulin-like%20growth%20factor%20receptor%20activation%20in%20breast%20cancer%20cells&journal=Br.%20J.%20Cancer&doi=10.1038%2Fsj.bjc.6603354&volume=95&pages=1220-1228&publication_year=2006&author=Byron%2CSA&author=Horwitz%2CKB&author=Richer%2CJK&author=Lange%2CCA&author=Zhang%2CX&author=Yee%2CD
• https://doi.org/10.1074%2Fjbc.273.16.9994
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9545345
• http://scholar.google.com/scholar_lookup?&title=Insulin%20receptor%20substrate-1%20is%20the%20predominant%20signaling%20molecule%20activated%20by%20insulin-like%20growth%20factor-I%2C%20insulin%2C%20and%20interleukin-4%20in%20estrogen%20receptor-positive%20human%20breast%20cancer%20cells&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.273.16.9994&volume=273&pages=9994-10003&publication_year=1998&author=Jackson%2CJG&author=White%2CMF&author=Yee%2CD
• https://doi.org/10.1038%2Fsj.onc.1204920
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11704861
• http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20breast%20cancer%20cell%20motility%20by%20insulin%20receptor%20substrate-2%20%28IRS-2%29%20in%20metastatic%20variants%20of%20human%20breast%20cancer%20cell%20lines&journal=Oncogene&doi=10.1038%2Fsj.onc.1204920&volume=20&pages=7318-7325&publication_year=2001&author=Jackson%2CJG&author=Zhang%2CX&author=Yoneda%2CT&author=Yee%2CD
• https://doi.org/10.1074%2Fjbc.M117.785832
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28320862
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427262
• http://scholar.google.com/scholar_lookup?&title=Differential%20involvement%20of%20the%20microtubule%20cytoskeleton%20in%20insulin%20receptor%20substrate%201%20%28IRS-1%29%20and%20IRS-2%20signaling%20to%20AKT%20determines%20the%20response%20to%20microtubule%20disruption%20in%20breast%20carcinoma%20cells&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M117.785832&volume=292&pages=7806-7816&publication_year=2017&author=Mercado-Matos%2CJ&author=Clark%2CJL&author=Piper%2CAJ&author=Janusis%2CJ&author=Shaw%2CLM
• https://doi.org/10.1158%2F1078-0432.CCR-15-0588
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26324738
• http://scholar.google.com/scholar_lookup?&title=Clinical%20and%20translational%20results%20of%20a%20phase%20II%2C%20randomized%20trial%20of%20an%20anti-IGF-1R%20%28Cixutumumab%29%20in%20women%20with%20breast%20cancer%20that%20progressed%20on%20endocrine%20therapy&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-15-0588&volume=22&pages=301-309&publication_year=2016&author=Gradishar%2CWJ&author=Yardley%2CDA&author=Layman%2CR&author=Sparano%2CJA&author=Chuang%2CE&author=Northfelt%2CDW
• https://doi.org/10.1210%2Fendo-126-2-891
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2404751
• http://scholar.google.com/scholar_lookup?&title=Multihormonal%20regulation%20of%20the%20progesterone%20receptor%20in%20MCF-7%20human%20breast%20cancer%20cells%3A%20interrelationships%20among%20insulin%2Finsulin-like%20growth%20factor-I%2C%20serum%2C%20and%20estrogen&journal=Endocrinology&doi=10.1210%2Fendo-126-2-891&volume=126&pages=891-898&publication_year=1990&author=Katzenellenbogen%2CBS&author=Norman%2CMJ
• https://doi.org/10.1073%2Fpnas.0905118106
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19706513
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732858
• http://scholar.google.com/scholar_lookup?&title=Protein%20kinases%20mediate%20ligand-independent%20derepression%20of%20sumoylated%20progesterone%20receptors%20in%20breast%20cancer%20cells&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.0905118106&volume=106&pages=14287-14292&publication_year=2009&author=Daniel%2CAR&author=Lange%2CCA
• https://doi.org/10.1038%2Fonc.2013.579
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24469035
• http://scholar.google.com/scholar_lookup?&title=Progesterone%20receptor-B%20enhances%20estrogen%20responsiveness%20of%20breast%20cancer%20cells%20via%20scaffolding%20PELP1-%20and%20estrogen%20receptor-containing%20transcription%20complexes&journal=Oncogene&doi=10.1038%2Fonc.2013.579&volume=34&pages=506-515&publication_year=2015&author=Daniel%2CAR&author=Gaviglio%2CAL&author=Knutson%2CTP&author=Ostrander%2CJH&author=D%E2%80%99Assoro%2CAB&author=Ravindranathan%2CP
• https://doi.org/10.1371%2Fjournal.pone.0074250
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24066126
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774754
• http://scholar.google.com/scholar_lookup?&title=SurvExpress%3A%20an%20online%20biomarker%20validation%20tool%20and%20database%20for%20cancer%20gene%20expression%20data%20using%20survival%20analysis&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0074250&volume=8&publication_year=2013&author=Aguirre-Gamboa%2CR&author=Gomez-Rueda%2CH&author=Martinez-Ledesma%2CE&author=Martinez-Torteya%2CA&author=Chacolla-Huaringa%2CR&author=Rodriguez-Barrientos%2CA
• https://link.springer.com/doi/10.1007/s10549-012-2164-8
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22821401
• http://scholar.google.com/scholar_lookup?&title=Patient-derived%20luminal%20breast%20cancer%20xenografts%20retain%20hormone%20receptor%20heterogeneity%20and%20help%20define%20unique%20estrogen-dependent%20gene%20signatures&journal=Breast%20Cancer%20Res.%20Treat.&doi=10.1007%2Fs10549-012-2164-8&volume=135&pages=415-432&publication_year=2012&author=Kabos%2CP&author=Finlay-Schultz%2CJ&author=Li%2CC&author=Kline%2CE&author=Finlayson%2CC&author=Wisell%2CJ
• https://link.springer.com/doi/10.1007/s10555-016-9653-x
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28025748
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396460
• http://scholar.google.com/scholar_lookup?&title=Patient-derived%20xenograft%20%28PDX%29%20models%20in%20basic%20and%20translational%20breast%20cancer%20research&journal=Cancer%20Metastasis%20Rev.&doi=10.1007%2Fs10555-016-9653-x&volume=35&pages=547-573&publication_year=2016&author=Dobrolecki%2CLE&author=Airhart%2CSD&author=Alferez%2CDG&author=Aparicio%2CS&author=Behbod%2CF&author=Bentires-Alj%2CM
• https://doi.org/10.1158%2F0008-5472.CAN-16-3541
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28729413
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600857
• http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20suppression%20by%20progesterone%20receptors%20is%20mediated%20by%20their%20modulation%20of%20estrogen%20receptors%20and%20RNA%20polymerase%20III&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-16-3541&volume=77&pages=4934-4946&publication_year=2017&author=Finlay-Schultz%2CJ&author=Gillen%2CAE&author=Brechbuhl%2CHM&author=Ivie%2CJJ&author=Matthews%2CSB&author=Jacobsen%2CBM
• https://doi.org/10.1210%2Fme.2007-0248
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17717077
• http://scholar.google.com/scholar_lookup?&title=Phosphorylation-dependent%20antagonism%20of%20sumoylation%20derepresses%20progesterone%20receptor%20action%20in%20breast%20cancer%20cells&journal=Mol.%20Endocrinol.&doi=10.1210%2Fme.2007-0248&volume=21&pages=2890-2906&publication_year=2007&author=Daniel%2CAR&author=Faivre%2CEJ&author=Lange%2CCA
• https://doi.org/10.1016%2Fj.celrep.2015.08.050
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26387946
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594158
• http://scholar.google.com/scholar_lookup?&title=Anti-estrogen%20resistance%20in%20human%20breast%20tumors%20is%20driven%20by%20JAG1-NOTCH4-dependent%20cancer%20stem%20cell%20activity&journal=Cell%20Rep.&doi=10.1016%2Fj.celrep.2015.08.050&volume=12&pages=1968-1977&publication_year=2015&author=Simoes%2CBM&author=O%E2%80%99Brien%2CCS&author=Eyre%2CR&author=Silva%2CA&author=Yu%2CL&author=Sarmiento-Castro%2CA
• https://doi.org/10.2174%2F0929867322666150416095744
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25882671
• http://scholar.google.com/scholar_lookup?&title=Factors%20promoting%20tamoxifen%20resistance%20in%20breast%20cancer%20via%20stimulating%20breast%20cancer%20stem%20cell%20expansion&journal=Curr.%20Med.%20Chem.&doi=10.2174%2F0929867322666150416095744&volume=22&pages=2360-2374&publication_year=2015&author=Ojo%2CD&author=Wei%2CF&author=Liu%2CY&author=Wang%2CE&author=Zhang%2CH&author=Lin%2CX
• https://doi.org/10.1158%2F0008-5472.CAN-12-0684
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22573715
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520534
• http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20tamoxifen%20is%20associated%20with%20loss%20of%20the%20type%20I%20insulin-like%20growth%20factor%20receptor%3A%20implications%20for%20breast%20cancer%20treatment&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-12-0684&volume=72&pages=3372-3380&publication_year=2012&author=Fagan%2CDH&author=Uselman%2CRR&author=Sachdev%2CD&author=Yee%2CD
• https://doi.org/10.1038%2Fonc.2015.488
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26876199
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982805
• http://scholar.google.com/scholar_lookup?&title=Disruption%20of%20insulin%20receptor%20function%20inhibits%20proliferation%20in%20endocrine-resistant%20breast%20cancer%20cells&journal=Oncogene&doi=10.1038%2Fonc.2015.488&volume=35&pages=4235-4243&publication_year=2016&author=Chan%2CJY&author=LaPara%2CK&author=Yee%2CD
• https://doi.org/10.1056%2FNEJM199002013220504
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2296271
• http://scholar.google.com/scholar_lookup?&title=Cathepsin%20D%20and%20prognosis%20in%20breast%20cancer&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJM199002013220504&volume=322&pages=297-302&publication_year=1990&author=Tandon%2CAK&author=Clark%2CGM&author=Chamness%2CGC&author=Chirgwin%2CJM&author=McGuire%2CWL
• https://doi.org/10.1038%2Fsj.onc.1206436
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12821935
• http://scholar.google.com/scholar_lookup?&title=Estrogen%20receptor-alpha%20regulates%20the%20degradation%20of%20insulin%20receptor%20substrates%201%20and%202%20in%20breast%20cancer%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1206436&volume=22&pages=4007-4016&publication_year=2003&author=Morelli%2CC&author=Garofalo%2CC&author=Bartucci%2CM&author=Surmacz%2CE
• https://doi.org/10.1073%2Fpnas.0530291100
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12629218
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC153034
• http://scholar.google.com/scholar_lookup?&title=Prospective%20identification%20of%20tumorigenic%20breast%20cancer%20cells&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.0530291100&volume=100&pages=3983-3988&publication_year=2003&author=Al-Hajj%2CM&author=Wicha%2CMS&author=Benito-Hernandez%2CA&author=Morrison%2CSJ&author=Clarke%2CMF
• https://doi.org/10.1016%2Fj.stem.2007.08.014
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18371393
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423808
• http://scholar.google.com/scholar_lookup?&title=ALDH1%20is%20a%20marker%20of%20normal%20and%20malignant%20human%20mammary%20stem%20cells%20and%20a%20predictor%20of%20poor%20clinical%20outcome&journal=Cell%20Stem%20Cell&doi=10.1016%2Fj.stem.2007.08.014&volume=1&pages=555-567&publication_year=2007&author=Ginestier%2CC&author=Hur%2CMH&author=Charafe-Jauffret%2CE&author=Monville%2CF&author=Dutcher%2CJ&author=Brown%2CM
• https://doi.org/10.1158%2F1078-0432.CCR-17-1381
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29363524
• http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20of%20ER-positive%20breast%20cancer%20to%20endocrine%20treatment%20confers%20an%20adaptive%20sensitivity%20to%20TRAIL%20through%20posttranslational%20downregulation%20of%20c-FLIP&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-17-1381&volume=24&pages=2452-2463&publication_year=2018&author=Piggott%2CL&author=Silva%2CA&author=Robinson%2CT&author=Santiago-Gomez%2CA&author=Simoes%2CBM&author=Becker%2CM
• https://doi.org/10.1101%2Fgad.995802
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12080086
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC186342
• http://scholar.google.com/scholar_lookup?&title=Mammalian%20cell%20size%20is%20controlled%20by%20mTOR%20and%20its%20downstream%20targets%20S6K1%20and%204EBP1%2FeIF4E&journal=Genes%20Dev.&doi=10.1101%2Fgad.995802&volume=16&pages=1472-1487&publication_year=2002&author=Fingar%2CDC&author=Salama%2CS&author=Tsou%2CC&author=Harlow%2CE&author=Blenis%2CJ
• https://doi.org/10.1128%2FMCB.25.11.4676-4682.2005
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15899869
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1140635
• http://scholar.google.com/scholar_lookup?&title=Graded%20mitogen-activated%20protein%20kinase%20activity%20precedes%20switch-like%20c-Fos%20induction%20in%20mammalian%20cells&journal=Mol.%20Cell.%20Biol.&doi=10.1128%2FMCB.25.11.4676-4682.2005&volume=25&pages=4676-4682&publication_year=2005&author=Mackeigan%2CJP&author=Murphy%2CLO&author=Dimitri%2CCA&author=Blenis%2CJ
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9331090
• http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20the%20p53%20tumor%20suppressor%20pathway%20in%20cell%20lines%20of%20the%20National%20Cancer%20Institute%20anticancer%20drug%20screen%20and%20correlations%20with%20the%20growth-inhibitory%20potency%20of%20123%20anticancer%20agents&journal=Cancer%20Res.&volume=57&pages=4285-4300&publication_year=1997&author=O%E2%80%99Connor%2CPM&author=Jackman%2CJ&author=Bae%2CI&author=Myers%2CTG&author=Fan%2CS&author=Mutoh%2CM
• https://doi.org/10.1093%2Fannonc%2Fmdt575
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24525703
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933249
• http://scholar.google.com/scholar_lookup?&title=Biomarker%20changes%20associated%20with%20the%20development%20of%20resistance%20to%20aromatase%20inhibitors%20%28AIs%29%20in%20estrogen%20receptor-positive%20breast%20cancer&journal=Ann.%20Oncol.&doi=10.1093%2Fannonc%2Fmdt575&volume=25&pages=605-610&publication_year=2014&author=Arnedos%2CM&author=Drury%2CS&author=Afentakis%2CM&author=A%E2%80%99Hern%2CR&author=Hills%2CM&author=Salter%2CJ
• https://doi.org/10.1530%2FERC-10-0046
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21734071
• http://scholar.google.com/scholar_lookup?&title=Changes%20in%20breast%20cancer%20biomarkers%20in%20the%20IGF1R%2FPI3K%20pathway%20in%20recurrent%20breast%20cancer%20after%20tamoxifen%20treatment&journal=Endocr.%20Relat.%20Cancer&doi=10.1530%2FERC-10-0046&volume=18&pages=565-577&publication_year=2011&author=Drury%2CSC&author=Detre%2CS&author=Leary%2CA&author=Salter%2CJ&author=Reis-Filho%2CJ&author=Barbashina%2CV
• https://link.springer.com/doi/10.1007/s12672-018-0343-8
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30229539
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434949
• http://scholar.google.com/scholar_lookup?&title=Insulin%20receptor%20substrate%20suppression%20by%20the%20tyrphostin%20NT157%20inhibits%20responses%20to%20insulin-like%20growth%20factor-I%20and%20insulin%20in%20breast%20cancer%20cells&journal=Hormones%20Cancer&doi=10.1007%2Fs12672-018-0343-8&volume=9&pages=371-382&publication_year=2018&author=Yang%2CY&author=Chan%2CJY&author=Temiz%2CNA&author=Yee%2CD
• https://link.springer.com/doi/10.1186/bcr1982
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18366788
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397524
• http://scholar.google.com/scholar_lookup?&title=Human%20breast%20cancer%20cell%20lines%20contain%20stem-like%20cells%20that%20self-renew%2C%20give%20rise%20to%20phenotypically%20diverse%20progeny%20and%20survive%20chemotherapy&journal=Breast%20Cancer%20Res.&doi=10.1186%2Fbcr1982&volume=10&publication_year=2008&author=Fillmore%2CCM&author=Kuperwasser%2CC
• https://doi.org/10.1093%2Fjnci%2Fdjn123
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18445819
• http://scholar.google.com/scholar_lookup?&title=Intrinsic%20resistance%20of%20tumorigenic%20breast%20cancer%20cells%20to%20chemotherapy&journal=J.%20Natl%20Cancer%20Inst.&doi=10.1093%2Fjnci%2Fdjn123&volume=100&pages=672-679&publication_year=2008&author=Li%2CX&author=Lewis%2CMT&author=Huang%2CJ&author=Gutierrez%2CC&author=Osborne%2CCK&author=Wu%2CMF
• https://doi.org/10.1158%2F1535-7163.MCT-13-0842
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25267499
• http://scholar.google.com/scholar_lookup?&title=The%20tyrphostin%20NT157%20suppresses%20insulin%20receptor%20substrates%20and%20augments%20therapeutic%20response%20of%20prostate%20cancer&journal=Mol.%20Cancer%20Ther.&doi=10.1158%2F1535-7163.MCT-13-0842&volume=13&pages=2827-2839&publication_year=2014&author=Ibuki%2CN&author=Ghaffari%2CM&author=Reuveni%2CH&author=Pandey%2CM&author=Fazli%2CL&author=Azuma%2CH
• https://doi.org/10.1158%2F0008-5472.CAN-12-3385
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23651636
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391644
• http://scholar.google.com/scholar_lookup?&title=Therapeutic%20destruction%20of%20insulin%20receptor%20substrates%20for%20cancer%20treatment&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-12-3385&volume=73&pages=4383-4394&publication_year=2013&author=Reuveni%2CH&author=Flashner-Abramson%2CE&author=Steiner%2CL&author=Makedonski%2CK&author=Song%2CR&author=Shir%2CA
• https://doi.org/10.1158%2F1535-7163.MCT-17-0377
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29440449
• http://scholar.google.com/scholar_lookup?&title=Impact%20of%20the%20anticancer%20drug%20NT157%20on%20tyrosine%20kinase%20signaling%20networks&journal=Mol.%20Cancer%20Ther.&doi=10.1158%2F1535-7163.MCT-17-0377&volume=17&pages=931-942&publication_year=2018&author=Su%2CSP&author=Flashner-Abramson%2CE&author=Klein%2CS&author=Gal%2CM&author=Lee%2CRS&author=Wu%2CJ
• https://citation-needed.springer.com/v2/references/10.1038/s41416-020-01094-y?format=refman&flavour=references
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Amy%20R.%20Dwyer
• http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Amy%20R.%20Dwyer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Thu%20H.%20Truong
• http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Thu%20H.%20Truong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carlos%20Perez%20Kerkvliet
• http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carlos%20Perez%20Kerkvliet%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kiran%20V.%20Paul
• http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kiran%20V.%20Paul%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Peter%20Kabos
• http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Peter%20Kabos%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carol%20A.%20Sartorius
• http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carol%20A.%20Sartorius%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carol%20A.%20Lange
• http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carol%20A.%20Lange%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• https://static-content.springer.com/esm/art%3A10.1038%2Fs41416-020-01094-y/MediaObjects/41416_2020_1094_MOESM1_ESM.docx
• https://s100.copyright.com/AppDispatchServlet?title=Insulin%20receptor%20substrate-1%20%28IRS-1%29%20mediates%20progesterone%20receptor-driven%20stemness%20and%20endocrine%20resistance%20in%20oestrogen%20receptor%2B%20breast%20cancer&author=Amy%20R.%20Dwyer%20et%20al&contentID=10.1038%2Fs41416-020-01094-y©right=The%20Author%28s%29%2C%20under%20exclusive%20licence%20to%20Cancer%20Research%20UK&publication=0007-0920&publicationDate=2020-11-04&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
• https://crossmark.crossref.org/dialog/?doi=10.1038/s41416-020-01094-y
• https://citation-needed.springer.com/v2/references/10.1038/s41416-020-01094-y?format=refman&flavour=citation
• https://doi.org/10.1007/s10555-024-10171-0
• https://doi.org/10.1038/s41523-023-00601-7
• https://doi.org/10.1186/s13058-022-01585-1
• https://doi.org/10.1186/s13058-022-01515-1
• https://doi.org/10.1038/s41467-022-30898-0
• https://www.protocols.io/
• https://www.natureindex.com/
• http://www.naturechina.com
• https://www.natureasia.com/ja-jp

Analytics and Tracking {📊}

• Google Analytics
• Google Tag Manager

Javascript Libraries {📚}

• Prism.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk